Genmab A/S Stock: price and insider trades · Denmark

Genmab A/S, classified in the Health Care sector, is a listed company based in Copenhagen, Denmark, founded in 1998. Its insiders report their share dealings to Finanstilsynet DK. The last twelve months, up to 18 October 2026, brought 8 filings signed by 8 insiders.

All open-market trades in the period are sales: 3 sales worth €280k, by 3 insiders, with no purchase on record. The largest single trade was a sale of €218k, published on 20 February 2026, equal to 0.0012% of the market capitalisation.

Half of the filings or more reach the Finanstilsynet DK feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

For context, the typical company on the same exchange (median of 74 companies) published 4 filings over the same period, against 8 filings here. Since 2005, the database holds 5 purchases and 26 sales by insiders of the company.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.